Terms ending in 2027
Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,697,711 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | |
| US 8,748,439 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | |
| US 8,748,438 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 8,900,565 | Indole Derivatives as Inhibitors of Histone Deacetylase In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,371,281 | Indole Derivatives as Inhibitors of Histone Deacetylase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 8,658,653 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | |
| US 8,735,404 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 7,732,454 | Inhibitors of Bruton's Tyrosine Kinase In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 8,563,563 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 8,067,395 | Inhibitors of Tyrosine Kinases and Uses Thereof In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| 2 more term ends in 2027 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12, all of them expiring within the 18 months from Nov 21, 2026.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.